[go: up one dir, main page]

Heneghan et al., 2013 - Google Patents

JAK-STAT and intestinal mucosal immunology

Heneghan et al., 2013

View PDF @Full View
Document ID
13192442498234086612
Author
Heneghan A
Pierre J
Kudsk K
Publication year
Publication venue
Jak-stat

External Links

Snippet

The intestinal mucosal immune system is challenged with bacteria, viruses, and parasites, in addition to food and environmental antigens, that require dynamic immune responsiveness for homeostasis. One central signaling pathway is JAK-STAT, which regulates the adaptive …
Continue reading at www.tandfonline.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

Similar Documents

Publication Publication Date Title
Heneghan et al. JAK-STAT and intestinal mucosal immunology
Dong Cytokine regulation and function in T cells
Georgescu et al. Advances in understanding the immunological pathways in psoriasis
Chung et al. Interleukin-17 family members in health and disease
Gaudino et al. Cross-talk between antigen presenting cells and T cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis
Minns et al. The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation
Pan et al. MDP-induced interleukin-1β processing requires Nod2 and CIAS1/NALP3
Shi et al. IL-21 induces an imbalance of Th17/Treg cells in moderate-to-severe plaque psoriasis patients
Bamias et al. New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation
Nistala et al. Th17 and regulatory T cells: rebalancing pro-and anti-inflammatory forces in autoimmune arthritis
Rosadini et al. Early innate immune responses to bacterial LPS
Mizoguchi Healing of intestinal inflammation by IL-22
Braumüller et al. The cytokine network in colorectal cancer: implications for new treatment strategies
Schiller et al. Biological and clinical effects of intravenous tumor necrosis factor-α administered three times weekly
Bhaumik et al. Cellular and molecular dynamics of Th17 differentiation and its developmental plasticity in the intestinal immune response
Manz et al. Emergency granulopoiesis
Locati et al. Macrophage activation and polarization as an adaptive component of innate immunity
Zenewicz et al. Recent advances in IL-22 biology
Liu et al. Cytokine responses against periodontal infection: protective and destructive roles.
Vojdani et al. Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15
Chen et al. TIGIT negatively regulates inflammation by altering macrophage phenotype
Bostick et al. Innate lymphoid cells in intestinal immunity and inflammation
Sheng et al. Human β-defensin-3 promotes intestinal epithelial cell migration and reduces the development of necrotizing enterocolitis in a neonatal rat model
Cassatella et al. Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators
Shen et al. Inhibition of Pim-1 kinase ameliorates dextran sodium sulfate-induced colitis in mice